| Altasciences has expertise in highly sensitive bioanalytical assays development for the quantitation of oligonucleotides in complex biological matrices. |
|
| Biodextris works with mid and large sized vaccine companies to develop, manufacture and test a wide range of biologic products for vaccine, pharmaceutical and other applications. |
|
| CellCarta offers a range of services to support the development of therapeutic modalities, biomarkers and companion diagnostic tests. |
|
| Canadian Alliance for Skills and Training in Life Sciences (CASTL) delivers world-class technical skills development and training in biomanufacturing. |
|
| The CERASP is a centre for technology transfer (CCTT) in the pharmaceutical sciences and connected industries, specializing in supporting businesses from early-stage discovery to scale-up and technical transfer for GMP-ready production to facilitate the commercialization journey. |
|
| CQIB is a life sciences incubator/accelerator offering laboratories and workspaces for start-up companies. |
|
|
DePTAQ Network
| DePTAQ provides provide a full range of services, from the initial design of RNA therapies to preclinical-scale production, formulation and delivery. Managed by IRCM, McGill University and Sherbrooke University. |
|
| Ebovir Biotechnologie is a biotech focused on the AI-driven research and development of RNA-based therapeutics, mRNA vaccines, and molecular diagnostics targeting infectious diseases and cancer. Ebovir’s Ebo-Pulmo™ is a novel stem-loop RNA innate immune activator designed to stimulate antiviral interferon pathways. |
|
| ECOGENE-21 is a Canadian nonprofit organization, patient-centered and internationally recognized for its robust experience and expertise in the design, execution, oversight, and monitoring of clinical trials. |
|
| Eder Therapeutics discovers RNA-targetable genes using whole-exome sequencing, identifies and validates novel targets for RNAi therapeutics across cardiovascular disease and pancreatitis, creating a scalable pipeline of precision medicines. |
|
| Epitopea, a transatlantic cancer immunotherapy company founded in 2021 between Cambridge (UK), and Montreal (CA), develops ready-to-use RNA-based immunotherapies for the treatment of difficult-to-cure cancers. |
|
| Espoir Biosciences is a biotechnology company dedicated to developing innovative therapies designed to stimulate axonal regeneration and repair in neurodegenerative diseases. The company is developing a portfolio of antisense oligonucleotides (ASOs) based on high-potential, first-in-class therapeutic targets. |
|
| Feldan is a biopharmaceutical company specializing in the development of treatments based on the intracellular delivery of therapeutic products. |
|
| Galenvs is a specialized precision developer & manufacturer of DNA/RNA oligonucleotides for therapeutics, offering services from proof-of-concept through in vitro validation and pilot-scale production. |
|
| Moderna has developed therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. |
|
| Molecular Forecaster combines world-class computational tools with deep domain expertise to tackle the toughest challenges in early-stage drug discovery. |
|
| Nanofacile accelerates and reduces the risks associated with R&D of lipid nanoparticle-based gene therapies with advanced, easy-to-use technology, which includes encapsulation recipes and an advanced microfluidic device. |
|
| Neiges is a drug discovery company leveraging its lab-grown ‘human miniature intestinal tissue’ platform to discover and develop novel therapeutics for gastrointestinal diseases. Neiges is focused on enabling the discovery of RNA-based therapies in inflammatory and immunology indications. |
|
| Nemrod Biotechnology specializes in the use of the advanced SELEX expertise in order to generate tailor-made aptamers with a variety of properties – targeted affinity, conformational dynamism, enzymatic activity – according to the needs of each project. |
|
| Neopharm Life Sciences offers a comprehensive suite of RNA analysis services designed to support researchers, pharmaceutical and biotech companies at every stage of the product development lifecycle, from early discovery to commercial launch and beyond. |
|
| NMX, a contract research partner, supports drug discovery targeting biological macromolecules of therapeutic interest. |
|
| Polaris Oligonucleotides is a Canadian-based biopharma services provider dedicated to advancing oligonucleotides science by leveraging cutting-edge synthetic chemistry. |
|
| Providence Therapeutics is an mRNA Medicines Platform company with over nine years of expertise, a proven mRNA Medicines Platform, a next-generation lipid nanoparticle (LNP) technology and can produce vaccines and therapeutics ranging from personalized to pandemic scales. |
|
| ResolveMass Laboratories Inc. is a leading Polymer synthesis and analytical laboratory specializing in advanced characterization services for biopharmaceuticals and complex molecules. |
|
| RNA Technologies and Therapeutics Inc. (RNA T&T) is a privately held company headquartered in Montreal, Canada. It specializes in designing, optimizing, and small to medium-scale production (mg to g) of RNA. |
|
| Royalmount has deep expertise in the technologies required for the precise and highly sensitive quantification of proteins, peptides, and oligonucleotides in complex biological matrices. Its teams develop and optimize tailored methods capable of addressing analytical challenges using technologies such as cell based assays, including ELISpot. |
|
| Rynd Biotech specializes in providing accurate, point-of-care testing solutions and discreet at-home testing. Its innovative technology aims to redefine STI management by automating diagnosis and prescription delivery upon positive test results. |
|
| Sparx is a human-genetic target validation platform that uses natural genetic experiments to identify which disease has the strongest causal evidence for a molecular target. |
|
| Spheroid AI is building an AI agent platform for mRNA therapeutic development targeting drug-resistant tumors. |
|
| For 25 years, TransBIOTech has been accelerating the preclinical development of new therapies by offering the expertise required for drug discovery: pharmacology, cellular and molecular biology, immunology, biochemistry, pharmacokinetics and toxicology. Member of the CCTT network. |
|
| WhiteLab Genomics develops and leverages its proprietary AI platform to accelerate and optimize genomic medicine research and development (gene, cell, and RNA therapies). |
|
